This website does not use profiling cookies of its own or belonging to other websites in order to send you advertising in line with your preferences, but exclusively technical cookie. If you wish to have more information or deny your consent to all or some of these cookies click here. If you access any of the elements below this banner you consent to the use of cookies. CLOSE work with us it en home about us products & therapies news & media congresses contacts Working all together to heed the needs of patients, constantly reseaching the most appropriate therapies Bellco, with 40 years’ experience, operates worldwide offering therapies and systems for the treatment of renal failure, multiple organ failure, sepsis and congestive heart failure with the goal of providing know-how, reliability and innovation to the scientific and medical communities. BELLCO FRANCE WILL ATTEND THE SN-SFD 2015 IN LYON (SEPTEMBER 29TH - OCTOBER 2ND) BELLCO DO BRASIL WILL ATTEND THE XVIII CONGRESSO PAULISTA DE NEFROLOGIA IN SÃO PAULO (SEPTEMBER 30TH - OCTOBER 3RD) BELLCO WILL ATTEND THE SINEPE 2015 IN VIESTE (OCTOBER 1ST – 3RD) FLEXYA™ Simply flexible FLEXYA™ was born of the experience and innovative technological vision: a versatile, complete and automated instrument designed for chronic patients. AMPLYA™ Simply beyond AMPLYA™ is a multitherapeutic system for critical care. Integration of multiple extracorporeal treatments - from the more conventional to adsorption treatments - widens the therapeutic opportunities in case of organ failure. CARPEDIEM™ The First Worldwide Therapeutic System designed for neonatal patients "Scientists invent kidney dialysis machine for babies and safely treat newborn with multiple organ failure." by The Lancet News & Events BELLCO FRANCE WILL ATTEND THE SN-SFD 2015 IN LYON (SEPTEMBER 29TH - OCTOBER 2ND) Bellco France will attend the SN-SFD 2015 in Lyon (booth no.2) 22 SEP BELLCO DO BRASIL WILL ATTEND THE XVIII CONGRESSO PAULISTA DE NEFROLOGIA IN SÃO PAULO (SEPTEMBER 30TH - OCTOBER 3RD) Bellco Do Brasil will attend the XVIII Congresso Paulista de Nefrologia (booth no.23) 16 SEP BELLCO WILL ATTEND THE SINEPE 2015 IN VIESTE (OCTOBER 1ST – 3RD) Bellco will attent the SINEPE 2015 at the I Melograni Hotel in Vieste (booth no.4) 5 SEP Chronic Line The international dialysis population, more and more diversified and elderly, exhibits increasingly critical clinical situations due to complications and comorbidity that progressively compromise the quality of life. The challenges for Bellco’s Therapeutic Dialysis are constant research and innovation for personalised therapies. This objective can be achieved thanks to a complete range of products and systems therapy derived from the sinergic combination of advanced engineering and medical and scientific know-how. Acute Line Complex clinical conditions, such as those of patients in intensive care, undergoing surgery, with multiple traumas, sepsis, multi-organ failure, cardiopathy, affected by immune pathologies and intoxication, require integrated therapeutic approaches capable of assuring versatility, functionality, rapidity and effectiveness. Collaborative Research Sharing of technical and scientific skills and experience between Bellco and the most authoritative members of the medical and scientific communities lies at the heart of the continuous research and development of correct therapies. Bellco Società unipersonale a r.l. Sede Legale Via Camurana, 1 41037 Mirandola (MO), Italy Tel. +39 0535 29111 - Fax +39 0535 25501 Iscritta presso il registro delle imprese di Modena n. 06157780963 - Capitale sociale Eur 5.000.000 i.v. privacy links Sito Internet a cura di BauWeb top